Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

5.72
Delayed Data
As of Aug 03
 -0.10 / -1.72%
Today’s Change
5.66
Today|||52-Week Range
10.26
-25.81%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues362.0M374.5M442.9M581.2M
 
 
 
 
 
Depreciation And Amortization1.4M946.0K5.6M--
 
 
 
 
 
Operating ExpensesGross Income----437.3M--
 
 
General Expenses16.9M24.5M29.8M34.9M
 
 
 
 
 
Total Operating Expenses18.3M25.5M35.4M34.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income343.7M349.1M407.5M546.3M
 
 
 
 
 
Extraordinary Charge-766.0K0.000.00-6.1M
 
 
 
Interest Expense On Debt36.1M29.0M24.9M39.2M
 
 
 
 
 
Other Expenses0.00391.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income307.4M327.1M401.9M501.3M
 
 
 
 
 
Income Taxes-108.0M-115.5M-137.3M-179.0M
 
 
 
 
 
Net Income199.4M211.7M264.5M322.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS139.7M139.7M139.8M158.2M
 
 
 
 
 
Shares To Calculate EPS Diluted177.4M146.4M159.3M173.1M
 
 
 
 
 
 
Earnings Per ShareEPS$1.15$1.45$1.66$1.86
 
 
 
 
 
EPS Diluted$1.15$1.45$1.66$1.86